7.4.2: Platelets, Apheresis, Leucocyte Depleted A single-donor platelet component containing less than 1 × 106 leucocytes. 7.4.2.1: Technical information
7.4.1: Platelets, Pooled, Buffy Coat Derived, Leucocyte Depleted A pool of platelets, derived from buffy coats, which contains less than 1 × 106 leucocytes. 7.…
7.3.3: Red Cells, Washed, Leucocyte Depleted A red cell component, containing less than 1 × 106 leucocytes, which has been washed with 0.9% w/v sodium chloride for inje…
7.3.2: Red Cells in Additive Solution, Leucocyte Depleted A red cell component derived from whole blood or collected by apheresis containing less than 1 × 106 leucocyte…
7.3.1: Red Cells, Leucocyte Depleted A red cell component containing less than 1 × 106 leucocytes. 7.3.1.1: Technical information A red cell c…
7.2.1: Whole Blood, Leucocyte Depleted A unit of blood collected into an anticoagulant, containing less than 1 × 106 leucocytes. 7.2.1.1: Technical information…
7.1.2: Irradiated components For the whole of this section X-irradiation may be regarded as equivalent to gamma irradiation. Times when irradiation should be undertaken and the pe…
7.1.5: References Dumont L, Dzik W, Rebulla P, Brandwein H and members of the BEST Expert Working Party of the ISBT (1996). Practical guidelines for process validation and proces…
7.1.4: Production advice The timing and method of separation depends on the components to be prepared from a given donation. If the production, washing or splitting process tr…
7.1.3: Other component specifications Other component and process monitoring specifications are detailed later in this chapter. As far as possible, all parameters tested should be deriv…
7.1.1: Leucocyte depletion With very few stated exceptions (e.g. granulocytes), from November 1999 all allogeneic blood components produced in the UK have been subjected to a leucocyte …
6.11: Transportation of blood components 6.11.1: General considerations Donated blood and blood components should be transported by a secure system using transit containers, p…
6.10: Release of components which do not conform to specified requirements Blood and/or blood components may be issued for research, for reagent and, in exceptional cases, for therapeuti…
6.7: Component storage 6.7.1: Specifications for component storage areas Storage areas for blood components must operate within a specified temperature range and should provid…
6.4: Component processing 6.4.1: Premises Component production areas should satisfy the requirements defined in the current Rules and Guidance for Pharmaceutical Manufactur…
6.3: Component and process monitoring tests These guidelines also indicate the minimum level of other process monitoring tests necessary to ensure components are prepared to specificatio…
2.3: Other standards There are a number of other standards that help define how a quality management system should be designed to meet the needs of a particular aspect of a …
2.1: Introduction The key requirements for Blood Establishments and for hospital blood banks are defined in the Blood Safety and Quality Regulations (Statutory Instrument 2005 No. 50) as…
dsg_wb_203_002_69_42_ol_01.zip (8MB)
16.8: Application of HLA testing to patient and donor investigations 16.8.1: Investigation of refractoriness Please refer to the relevant EFI Standards for Transfusion. …
CN 02-2024 - Tropical Virus Risks in the GDRI v1.pdf (1MB)